$rVRXA
Veraxa Biotech is a Switzerland-based, pre-clinical and early clinical-stage biopharmaceutical company leveraging its proprietary BiTAC platform and high-throughput single-cell screening system to develop next-generation bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs) for solid and hematological tumors.
$2.28
$1.14
1
$0.00
Veraxa Biotech AG Reality Metrics
Metric
Show % of Total
Key Facts
Name
Veraxa Biotech AG Reality
Ticker
rVRXA
CUSIP
—
ISIN
—
Platform
Tokenization
Type
Type
Tokenization Sponsorship
Third-Party
Type
—
Asset Manager
—
Asset Class
Underlying Security
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management
Fees
Fees
0%
Performance
Fees
Fees
0%
Market Data
Total Value
$2
▲
NAV
$1.14
Price
—
Token Supply
2.00
△
Circulating Supply
2.00
△
7D APY
—
30D APY
—
Holders
1
△
Trailing 30D
Active Addresses
Active Addresses
—
Monthly
Transfer Count
Transfer Count
1
△
Monthly
Transfer Volume
Transfer Volume
$0
△
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDCUSDT
Subscription Time
Instant
Min.
Investment
Investment
20 USDC
Subscription
Fees
Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDC
Redemption
Fees
Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Asset Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
Alpaca Securities LLC
0001702580Crypto Custodian
—
Fund Administrator
—
Traditional Broker
Alpaca SecuritiesCrypto Broker
—
Auditor
The Network FirmTransfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account
Segregation
Segregation
Bankruptcy
Remote
Remote
Deposit
Insurance
Insurance
Fees
Management
Fees
Fees
0%
Performance
Fees
Fees
0%
Other Fees
—
Redemption
Fees
Fees
0.10%
Subscription
Fees
Fees
0.10%
RWA.xyzAll Rights Reserved